<DOC>
	<DOCNO>NCT00958230</DOCNO>
	<brief_summary>The study design produce early safety performance data small group patient require repair peripheral vascular endarterectomy ( incision artery feed limbs require patch repair incision removal atherosclerotic plaque stop usual blood flow limb ) . Data collect show procedure safe allow normal blood flow resume . Data use facilitate CE Mark submission .</brief_summary>
	<brief_title>dCell Vascular Patch Peripheral Vascular Surgery Study CE Mark Submission</brief_title>
	<detailed_description />
	<criteria>1 . Patients scheduled remote open peripheral vascular endarterectomy 2 . Lack suitable autologous material function closure patch arteriotomy 3 . Uncomplicated standard elective endarterectomy procedure ( peroperative inclusion criterion ) 4 . Use dCell™ Vascular Patch arteriotomy closure material ( peroperative inclusion criterion ) 5 . Patients 18 80 year old , inclusive 6 . Haemoglobin &gt; 9 g/dL platelet count &gt; 100,000/mm3 prior Day 1 7 . Other haematological biochemical parameter within range acceptable administration general anesthesia prior Day 1 8 . Ability communicate meaningfully investigative staff , competence give write informed consent , ability comply entire study procedure 9 . Duly execute , write , informed consent obtain patient 1 . Known serious allergy contrast agent use angiography 2 . Treatment investigational drug device within 60 day prior study entry ( Day 1 ) 3 . If female childbearing potential : evidence positive pregnancy test state intention become pregnant next 612 month 4 . Patients receive revision exist graft 5 . Patients demonstrate active local systemic infection ( WBC &gt; 15,000/mm3 ) 6 . Any condition judgment Investigator would preclude adequate evaluation dCell™ Vascular Patch 's safety performance 7 . Patients vitamin K antagonist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>endarterectomy</keyword>
	<keyword>dCell</keyword>
	<keyword>Tissue Regenix Ltd</keyword>
	<keyword>TRL</keyword>
	<keyword>Vascular Patch</keyword>
	<keyword>Treatment</keyword>
</DOC>